Physiologic and behavioral indicators of energy deficiency in female adolescent runners with elevated bone turnover

Am J Clin Nutr. 2010 Sep;92(3):652-9. doi: 10.3945/ajcn.2009.28926. Epub 2010 Jul 7.

Abstract

Background: Female adolescent runners have an elevated prevalence of low bone mass for agemdashan outcome that may be partially due to inadequate energy intake.

Objective: The objective was to evaluate diet, menstrual history, serum hormone concentrations, and bone mass in female adolescent runners with normal or abnormal bone turnover.

Design: Thirty-nine cross-country runners (age: 15.7 plusmn 0.2 y) participated in the study, which included a 7-d dietary assessment with the use of a food record and daily 24-h dietary recalls; serum measures of insulin-like growth factor I, estradiol, leptin, parathyroid hormone, progesterone, triiodothyronine, 25-hydroxycholecalciferol, bone-specific alkaline phosphatase (BAP), and cross-linked C-telopeptides of type I collagen (CTX); an evaluation of height, weight, bone mass, and body composition with the use of dual-energy X-ray absorptiometry; and a questionnaire to assess menses and sports participation. Age- and sex-specific BAP and CTX concentrations of at least the 97th percentile and no greater than the third percentile, respectively, were considered abnormal.

Results: All abnormal BAP and CTX concentrations fell within the elevated ( ge 97%) range. Runners with an elevated bone turnover (EBT) (n = 13) had a lower body mass, fewer menstrual cycles in the past year, lower estradiol and 25-hydroxycholecalciferol concentrations, and a higher prevalence of body mass index lt 10% for age, vitamin D insufficiency, amenorrhea, and low bone mass. Girls with EBT consumed less than the recommended amounts of energy and had a higher prevalence of consuming lt 1300 mg Ca than did those with normal bone turnover.

Conclusions: Runners with EBT had a profile consistent with energy deficiency. Nutritional support to increase energy, calcium intake, and 25-hydroxycholecalciferol concentrations may improve bone mineral accrual in young runners with EBT. This trial was registered at clinicaltrials.gov as NCT01059968.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adolescent
  • Alkaline Phosphatase / blood*
  • Amenorrhea / blood
  • Athletes
  • Biomarkers / blood
  • Body Mass Index
  • Body Weight*
  • Bone Density
  • Bone Remodeling / physiology*
  • Calcium, Dietary / administration & dosage
  • Collagen Type I / blood*
  • Diet Records
  • Diet Surveys
  • Diet*
  • Energy Intake*
  • Estradiol / blood
  • Female
  • Humans
  • Menstruation / physiology
  • Peptides / blood*
  • Running / physiology*
  • Vitamin D / analogs & derivatives
  • Vitamin D / blood
  • Vitamin D Deficiency / blood

Substances

  • Biomarkers
  • Calcium, Dietary
  • Collagen Type I
  • Peptides
  • collagen type I trimeric cross-linked peptide
  • Vitamin D
  • Estradiol
  • 25-hydroxyvitamin D
  • Alkaline Phosphatase

Associated data

  • ClinicalTrials.gov/NCT01059968